Dr. Langston joined the faculty of Stanford University School of Medicine in 2022. He received his PhD in Epidemiology from the University of Arizona’s College of Public Health followed by postdoctoral training in Cancer Prevention and Control at Washington University in Saint Louis School of Medicine. Dr. Langston focuses on the epidemiology of benign and malignant prostate conditions. Currently, he is funded by a NIDDK K01 to use machine learning approaches to tailor treatment for BPH/LUTS.